It is a pharma private limited company based in Chinhat, Uttar Pradesh, India, established in 2018.
2018 | Chinhat, Uttar Pradesh, India | ActiveAspia Parenteral Private Limited, a active private limited company, was established on 19 December 2018 in Chinhat, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U51909UP2018PTC111467. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹8.70 Cr and a paid-up capital of ₹8.70 Cr.
Its leadership includes Dimpal Singh (Director), Praveen Singh (Director), Mukesh Kumar (Director). Past directors included Dharmendra Yadav, Meera Singh, Saurabh Yadav. It holds ₹15.54 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at F.No D-202 Shri Sai Apartment Anaura Faizabad Road, Chinhat, Uttar Pradesh, 226028.
U51909UP2018PTC111467
111467
19 December 2018
₹8.70 Cr
₹8.70 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Aspia Parenteral Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dimpal Singh | Director | 07 Feb 2025 | Current |
| Praveen Singh | Director | 20 Apr 2021 | Current |
| Mukesh Kumar | Director | 24 Oct 2019 | Current |
| Mamta | Director | 19 Dec 2018 | Current |
| Surajman Vishvakarma | Director | 08 Dec 2023 | Current |
| Geeta Singh | Director | 24 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 May 2025 | Past |
| Pramod Abcsdd | Director | 20 Apr 2021 | Past |
| Pramod Abcsdd | Director | 24 Jan 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aspia Parenteral Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 8158.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aspia Parenteral had a public holding of 55.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹155,400,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2022 | State Bank Of India | ₹15.54 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Aspia Parenteral, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aspia Parenteral, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspia Parenteral's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Geeta Singh was appointed as a Director was appointed as a Director on 24 Apr 2025 & has been associated with this company since 7 months 26 days . was documented.
The activity Dimpal Singh was appointed as a Director was appointed as a Director on 07 Feb 2025 & has been associated with this company since 10 months 10 days . was completed.
Vinod Kumar Singh was appointed as a Director was appointed as a Director on 07 Feb 2025 & has been associated with this company since 10 months 10 days . was recorded as a recent event.
The activity Aspia Parenteral Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge with State Bank Of India of Rs. 15.54 Cr registered on 08 Feb 2022 with Charge ID 100540675 was modified on 31 May 2024. was recorded as a recent event.
The activity Aspia Parenteral Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
The CIN of Aspia Parenteral Private Limited is U51909UP2018PTC111467.
Aspia Parenteral Private Limited is headquartered at F.No D-202 Shri Sai Apartment Anaura Faizabad Road, Chinhat, Uttar Pradesh, 226028.
Aspia Parenteral Private Limited was incorporated on 19 December 2018.
The current directors of Aspia Parenteral Private Limited are
The primary industry of Aspia Parenteral Private Limited is Manufacturing.
Aspia Parenteral Private Limited is unlisted.
The authorized capital of Aspia Parenteral Private Limited is ₹8.70 Cr, and the paid-up capital is ₹8.70 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX